[1]
P. A. Sloan, MD and R. L. Barkin, PharmD, MBA, “Oxymorphone and oxymorphone extended release: A pharmacotherapeutic review”, J of Opioid Management, vol. 4, no. 3, pp. 131–144, Jan. 2018.